Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study Experiences
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05967494 |
|
Recruitment Status :
Not yet recruiting
First Posted : August 1, 2023
Last Update Posted : August 1, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The study seeks to delve into the firsthand experiences of patients diagnosed with chronic fatigue syndrome who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals.
The data collected from this study will help improve future outcomes for all chronic fatigue syndrome patients as well as those in under-represented demographic groups.
| Condition or disease |
|---|
| Chronic Fatigue Syndrome |
| Study Type : | Observational |
| Estimated Enrollment : | 500 participants |
| Observational Model: | Case-Crossover |
| Time Perspective: | Prospective |
| Official Title: | Assessing Patient Engagement and Understanding in Chronic Fatigue Syndrome Clinical Trials |
| Estimated Study Start Date : | August 2024 |
| Estimated Primary Completion Date : | August 2025 |
| Estimated Study Completion Date : | August 2026 |
- Rate of patients who decide to join in a chronic fatigue syndrome clinical trial [ Time Frame: 3 months ]
- Number of chronic fatigue syndrome patients who remain in clinical trial until completion [ Time Frame: 12 months ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Signed Written Informed Consent
- Aged ≥ 18 years old
- No prior treatment for chronic fatigue syndrome
Exclusion Criteria:
- Participant is actively receiving study therapy in another
- Inability to provide written informed consent
- Women of childbearing potential without a negative pregnancy test; or women who are lactating.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05967494
| Contact: Michael B Gill | (415) 900-4227 | bask@withpower.com |
| United States, California | |
| Power Life Sciences | |
| San Francisco, California, United States, 94107 | |
| Contact: Michael B Gill 415-900-4227 https://www.withpower.com/contact-us@withpower.com | |
| Study Director: | Michael B Gill | Power Life Sciences Inc. |
| Responsible Party: | Power Life Sciences Inc. |
| ClinicalTrials.gov Identifier: | NCT05967494 |
| Other Study ID Numbers: |
84606875 |
| First Posted: | August 1, 2023 Key Record Dates |
| Last Update Posted: | August 1, 2023 |
| Last Verified: | July 2023 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Chronic Fatigue Syndrome |
|
Fatigue Syndrome, Chronic Syndrome Fatigue Disease Pathologic Processes Muscular Diseases Musculoskeletal Diseases |
Encephalomyelitis Neuroinflammatory Diseases Nervous System Diseases Neuromuscular Diseases Chronic Disease Disease Attributes |